Showing 1–6 of 6 results for author: Dorsey, E R

Accessible, At-Home Detection of Parkinson's Disease via Multi-task Video Analysis

Authors: Md Saiful Islam, Tariq Adnan, Jan Freyberg, Sangwu Lee, Abdelrahman Abdelkader, Meghan Pawlik, Cathe Schwartz, Karen Jaffe, Ruth B. Schneider, E Ray Dorsey, Ehsan Hoque

Abstract: Limited access to neurological care leads to missed diagnoses of Parkinson's disease (PD), leaving many individuals unidentified and untreated. We trained a novel neural network-based fusion architecture to detect Parkinson's disease (PD) by analyzing features extracted from webcam recordings of three tasks: finger tap**, facial expression (smiling), and speech (uttering a sentence containing al… ▽ More Limited access to neurological care leads to missed diagnoses of Parkinson's disease (PD), leaving many individuals unidentified and untreated. We trained a novel neural network-based fusion architecture to detect Parkinson's disease (PD) by analyzing features extracted from webcam recordings of three tasks: finger tap**, facial expression (smiling), and speech (uttering a sentence containing all letters of the alphabet). Additionally, the model incorporated Monte Carlo Dropout to improve prediction accuracy by considering uncertainties. The study participants (n = 845, 272 with PD) were randomly split into three sets: 60% for training, 20% for model selection (hyper-parameter tuning), and 20% for final performance evaluation. The dataset consists of 1102 sessions, each session containing videos of all three tasks. Our proposed model achieved significantly better accuracy, area under the ROC curve (AUROC), and sensitivity at non-inferior specificity compared to any single-task model. Withholding uncertain predictions further boosted the performance, achieving 88.0% (95% CI: 87.7% - 88.4%) accuracy, 93.0% (92.8% - 93.2%) AUROC, 79.3% (78.4% - 80.2%) sensitivity, and 92.6% (92.3% - 92.8%) specificity, at the expense of not being able to predict for 2.3% (2.0% - 2.6%) data. Further analysis suggests that the trained model does not exhibit any detectable bias across sex and ethnic subgroups and is most effective for individuals aged between 50 and 80. This accessible, low-cost approach requiring only an internet-enabled device with a webcam and microphone paves the way for convenient PD screening at home, particularly in regions with limited access to clinical specialists. △ Less

Submitted 21 June, 2024; originally announced June 2024.

Using AI to Measure Parkinson's Disease Severity at Home

Authors: Md Saiful Islam, Wasifur Rahman, Abdelrahman Abdelkader, Phillip T. Yang, Sangwu Lee, Jamie L. Adams, Ruth B. Schneider, E. Ray Dorsey, Ehsan Hoque

Abstract: We present an artificial intelligence system to remotely assess the motor performance of individuals with Parkinson's disease (PD). Participants performed a motor task (i.e., tap** fingers) in front of a webcam, and data from 250 global participants were rated by three expert neurologists following the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The neurologis… ▽ More We present an artificial intelligence system to remotely assess the motor performance of individuals with Parkinson's disease (PD). Participants performed a motor task (i.e., tap** fingers) in front of a webcam, and data from 250 global participants were rated by three expert neurologists following the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The neurologists' ratings were highly reliable, with an intra-class correlation coefficient (ICC) of 0.88. We developed computer algorithms to obtain objective measurements that align with the MDS-UPDRS guideline and are strongly correlated with the neurologists' ratings. Our machine learning model trained on these measures outperformed an MDS-UPDRS certified rater, with a mean absolute error (MAE) of 0.59 compared to the rater's MAE of 0.79. However, the model performed slightly worse than the expert neurologists (0.53 MAE). The methodology can be replicated for similar motor tasks, providing the possibility of evaluating individuals with PD and other movement disorders remotely, objectively, and in areas with limited access to neurological care. △ Less

Submitted 17 August, 2023; v1 submitted 30 March, 2023; originally announced March 2023.

Remote Medication Status Prediction for Individuals with Parkinson's Disease using Time-series Data from Smartphones

Authors: Weijian Li, Wei Zhu, E. Ray Dorsey, Jiebo Luo

Abstract: Medication for neurological diseases such as the Parkinson's disease usually happens remotely away from hospitals. Such out-of-lab environments pose challenges in collecting timely and accurate health status data. Individual differences in behavioral signals collected from wearable sensors also lead to difficulties in adopting current general machine learning analysis pipelines. To address these c… ▽ More Medication for neurological diseases such as the Parkinson's disease usually happens remotely away from hospitals. Such out-of-lab environments pose challenges in collecting timely and accurate health status data. Individual differences in behavioral signals collected from wearable sensors also lead to difficulties in adopting current general machine learning analysis pipelines. To address these challenges, we present a method for predicting the medication status of Parkinson's disease patients using the public mPower dataset, which contains 62,182 remote multi-modal test records collected on smartphones from 487 patients. The proposed method shows promising results in predicting three medication statuses objectively: Before Medication (AUC=0.95), After Medication (AUC=0.958), and Another Time (AUC=0.976) by examining patient-wise historical records with the attention weights learned through a Transformer model. Our method provides an innovative way for personalized remote health sensing in a timely and objective fashion which could benefit a broad range of similar applications. △ Less

Submitted 30 May, 2023; v1 submitted 25 July, 2022; originally announced July 2022.

Comments: Accepted to ICDH-2023. Camera ready with supplementary material

Facial expressions can detect Parkinson's disease: preliminary evidence from videos collected online

Authors: Mohammad Rafayet Ali, Taylor Myers, Ellen Wagner, Harshil Ratnu, E. Ray Dorsey, Ehsan Hoque

Abstract: One of the symptoms of Parkinson's disease (PD) is hypomimia or reduced facial expressions. In this paper, we present a digital biomarker for PD that utilizes the study of micro-expressions. We analyzed the facial action units (AU) from 1812 videos of 604 individuals (61 with PD and 543 without PD, mean age 63.9 yo, sd 7.8 ) collected online using a web-based tool (www.parktest.net). In these vide… ▽ More One of the symptoms of Parkinson's disease (PD) is hypomimia or reduced facial expressions. In this paper, we present a digital biomarker for PD that utilizes the study of micro-expressions. We analyzed the facial action units (AU) from 1812 videos of 604 individuals (61 with PD and 543 without PD, mean age 63.9 yo, sd 7.8 ) collected online using a web-based tool (www.parktest.net). In these videos, participants were asked to make three facial expressions (a smiling, disgusted, and surprised face) followed by a neutral face. Using techniques from computer vision and machine learning, we objectively measured the variance of the facial muscle movements and used it to distinguish between individuals with and without PD. The prediction accuracy using the facial micro-expressions was comparable to those methodologies that utilize motor symptoms. Logistic regression analysis revealed that participants with PD had less variance in AU6 (cheek raiser), AU12 (lip corner puller), and AU4 (brow lowerer) than non-PD individuals. An automated classifier using Support Vector Machine was trained on the variances and achieved 95.6% accuracy. Using facial expressions as a biomarker for PD could be potentially transformative for patients in need of physical separation (e.g., due to COVID) or are immobile. △ Less

Submitted 9 December, 2020; originally announced December 2020.

Journal ref: npj Digital Medicine 2021

Predicting Parkinson's Disease with Multimodal Irregularly Collected Longitudinal Smartphone Data

Authors: Weijian Li, Wei Zhu, E. Ray Dorsey, Jiebo Luo

Abstract: Parkinsons Disease is a neurological disorder and prevalent in elderly people. Traditional ways to diagnose the disease rely on in-person subjective clinical evaluations on the quality of a set of activity tests. The high-resolution longitudinal activity data collected by smartphone applications nowadays make it possible to conduct remote and convenient health assessment. However, out-of-lab tests… ▽ More Parkinsons Disease is a neurological disorder and prevalent in elderly people. Traditional ways to diagnose the disease rely on in-person subjective clinical evaluations on the quality of a set of activity tests. The high-resolution longitudinal activity data collected by smartphone applications nowadays make it possible to conduct remote and convenient health assessment. However, out-of-lab tests often suffer from poor quality controls as well as irregularly collected observations, leading to noisy test results. To address these issues, we propose a novel time-series based approach to predicting Parkinson's Disease with raw activity test data collected by smartphones in the wild. The proposed method first synchronizes discrete activity tests into multimodal features at unified time points. Next, it distills and enriches local and global representations from noisy data across modalities and temporal observations by two attention modules. With the proposed mechanisms, our model is capable of handling noisy observations and at the same time extracting refined temporal features for improved prediction performance. Quantitative and qualitative results on a large public dataset demonstrate the effectiveness of the proposed approach. △ Less

Submitted 15 October, 2020; v1 submitted 24 September, 2020; originally announced September 2020.

Comments: Accepted to ICDM-20

High Frequency Remote Monitoring of Parkinson's Disease via Smartphone: Platform Overview and Medication Response Detection

Authors: Andong Zhan, Max A. Little, Denzil A. Harris, Solomon O. Abiola, E. Ray Dorsey, Suchi Saria, Andreas Terzis

Abstract: Objective: The aim of this study is to develop a smartphone-based high-frequency remote monitoring platform, assess its feasibility for remote monitoring of symptoms in Parkinson's disease, and demonstrate the value of data collected using the platform by detecting dopaminergic medication response. Methods: We have developed HopkinsPD, a novel smartphone-based monitoring platform, which measures s… ▽ More Objective: The aim of this study is to develop a smartphone-based high-frequency remote monitoring platform, assess its feasibility for remote monitoring of symptoms in Parkinson's disease, and demonstrate the value of data collected using the platform by detecting dopaminergic medication response. Methods: We have developed HopkinsPD, a novel smartphone-based monitoring platform, which measures symptoms actively (i.e. data are collected when a suite of tests is initiated by the individual at specific times during the day), and passively (i.e. data are collected continuously in the background). After data collection, we extract features to assess measures of five key behaviors related to PD symptoms -- voice, balance, gait, dexterity, and reaction time. A random forest classifier is used to discriminate measurements taken after a dose of medication (treatment) versus before the medication dose (baseline). Results: A worldwide study for remote PD monitoring was established using HopkinsPD in July, 2014. This study used entirely remote, online recruitment and installation, demonstrating highly cost-effective scalability. In six months, 226 individuals (121 PD and 105 controls) contributed over 46,000 hours of passive monitoring data and approximately 8,000 instances of structured tests of voice, balance, gait, reaction, and dexterity. To the best of our knowledge, this is the first study to have collected data at such a scale for remote PD monitoring. Moreover, we demonstrate the initial ability to discriminate treatment from baseline with 71.0(+-0.4)% accuracy, which suggests medication response can be monitored remotely via smartphone-based measures. △ Less

Submitted 5 January, 2016; originally announced January 2016.